A research team has unveiled new insights into how weather influences the spread of dengue fever. The study identifies temperature and rainfall as critical factors driving the global surge in dengue ...

First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention ...

First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger travelers.On track for commercial launch in the U.S. in the ...

The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ...

Here’s a look at Zika virus, an illness spread through mosquito bites that can cause birth defects and other neurological defects. Facts Sources: Centers for Disease Control and Prevention (CDC), ...

As per the World Health Organisation report (WHO), dengue cases surged from 4.1 million in 2023 to over 10.6 million in 2024 ...

The illness typically lasts two to seven days, but severe cases can be deadly. An affected person will have flu-like symptoms ...

Three species of mosquito are of particular concern in Europe, according to the European Centre for Disease Prevention and ...

The trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.

The VI Department of Health is closely monitoring H5N1, commonly referred as bird flu or avian flu, and recent developments in the U.S. mainland and Puerto Rico. Recently H5N1 was detected in a ...

A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.

Feb. 5, 2025 — Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful ...